Showing 1 to 1 of 1 results
theguardian.com
🌐 85% Global Worthiness
NHS England Offers Injectable Cancer Immunotherapy
NHS England becomes the first in Europe to offer injectable nivolumab, an immunotherapy, to treat up to 15,000 cancer patients annually, saving significant time compared to intravenous infusions and improving patient access.
NHS England Offers Injectable Cancer Immunotherapy
NHS England becomes the first in Europe to offer injectable nivolumab, an immunotherapy, to treat up to 15,000 cancer patients annually, saving significant time compared to intravenous infusions and improving patient access.
Progress
40% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results